Hepatitis B Virus Clinical Trials

73 clinical trials for Hepatitis B Virus across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic — RECRUITING
HepB mAb19 in Individuals With Chronic Hepatitis B Infection — RECRUITING · PHASE1
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors — RECRUITING · PHASE4
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study — RECRUITING
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED MULTICENTER PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF ALG-000184 COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN UNTREATED HBEAG-POSITIVE AND HBEAG-NEGATIVE ADULT SUBJECTS WITH CHRONIC HEPATITIS B VIRUS INFECTION (B-SUPREME) — RECRUITING · PHASE2
Impact of Hepatitis B Virus on Inflammatory Bowel Disease — RECRUITING
A PHASE 2B, MULTI-CENTRE, RANDOMIZED, PARTIALLY PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF SEQUENTIAL THERAPY WITH DAPLUSIRAN/TOMLIGISIRAN FOLLOWED BY BEPIROVIRSEN IN PARTICIPANTS WITH CHRONIC HEPATITIS B VIRUS ON BACKGROUND NUCLEOS(T)IDE ANALOGUE THERAPY (B-UNITED) — RECRUITING · PHASE2
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF TREATMENT WITH BEPIROVIRSEN IN PARTICIPANTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS AND CHRONIC HEPATITIS B VIRUS INFECTION ON ANTIRETROVIRAL TREATMENT — RECRUITING
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. — RECRUITING · NA
A PHASE 2 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF REGIMENS CONTAINING VIR-2218, VIR-3434, AND/OR PEG-IFN¿ IN SUBJECTS WITH CHRONIC HEPATITIS B VIRUS INFECTION — RECRUITING · PHASE2
A PHASE 1B/2A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY EVALUATING THE SAFETY, ANTI-VIRAL ACTIVITY, AND PHARMACOKINETICS OF AB-423, A HBV CORE INHIBITOR, IN NON-CIRRHOTIC, HBV-DNA POSITIVE SUBJECTS WITH CHRONIC HBV INFECTION — RECRUITING · PHASE1
A PHASE 2, OPEN-LABEL, RANDOMIZED, TWO PART, MULTIPLE DOSE STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFICACY OF SB 9200 IN SUBJECTS INFECTED WITH CHRONIC HEPATITIS B VIRUS — RECRUITING · PHASE2
A PHASE I/IB RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED AND DOSE-FINDING STUDY TO EVALUATE THE SAFETY, AND TOLERABILITY OF SINGLE (SD) AND MULTIPLE (MD) DOSES OF AN ADENOVIRUS SEROTYPE 5 (AD5) VECTOR BASED IMMUNOTHERAPEUTIC PRODUCT, TG1050, AND AN INITIAL EVALUATION OF IMMUNOLOGIC AND ANTIVIRAL ACTIVITY OF TG1050 IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B INFECTION — RECRUITING · PHASE1
A MULTI-CENTRE PHASE III STUDY TO EVALUATE PRE-EMPTIVE TENOFOVIR FOR PREVENTION OF HEPATITIS B VIRUS REACTIVATION IN HBSAG NEGATIVE/ANTI-HBC POSITIVE INDIVIDUALS UNDERGOING RITUXIMAB-BASED CHEMOTHERAPY FOR NON-HODGKIN'S LYMPHOMA/SMALL LYMPHOCYTIC LEUKEMIA. — RECRUITING · PHASE3
A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF GS-4774 IN COMBINATION WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF SUBJECTS WITH CHRONIC HEPATITIS B AND WHO ARE CURRENTLY NOT ON TREATMENT — RECRUITING · PHASE2
Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District — COMPLETED · PHASE4
NK Cell Deregulation in HBV Patients — ACTIVE_NOT_RECRUITING · NA
Mutations of the Pre-core Region of Hepatite B Virus (HBV) — COMPLETED
Combating Related Epidemics in HCV — NOT_YET_RECRUITING · PHASE4
A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients — NOT_YET_RECRUITING · PHASE2
The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms — NOT_YET_RECRUITING
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France — NOT_YET_RECRUITING · NA
To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients — NOT_YET_RECRUITING · PHASE2
Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes — NOT_YET_RECRUITING · PHASE3
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF AB-101, AN ORAL PD-L1 INHIBITOR, IN HEALTHY SUBJECTS AND SUBJECTS WITH CHRONIC HBV INFECTION — COMPLETED
A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting — COMPLETED · PHASE1
Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy — WITHDRAWN · PHASE1
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma — NOT_YET_RECRUITING
PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, STUDY TO ASSESS THE EFFICACY AND SAFETY OF TREATMENT WITH BEPIROVIRSEN IN NUCLEOS(T)IDE ANALOGUE TREATED PARTICIPANTS WITH CHRONIC HEPATITIS B VIRUS (B-WELL 1) — COMPLETED · PHASE3
PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, STUDY TO ASSESS THE EFFICACY AND SAFETY OF TREATMENT WITH BEPIROVIRSEN IN HBEAG NEGATIVE NUCLEOS(T)IDE ANALOGUE TREATED PARTICIPANTS WITH CHRONIC HEPATITIS B VIRUS (B WELL 2) — COMPLETED · PHASE3
Effects of Antiviral Therapy on Patients With HBV-related HCC — COMPLETED
RANDOMISED, OPEN-LABEL AND PARALLEL GROUP TRIAL TO INVESTIGATE THE EFFECTS OF ORAL BI 685509 ALONE OR IN COMBINATION WITH EMPAGLIFLOZIN ON PORTAL HYPERTENSION AFTER 8 WEEKS TREATMENT IN PATIENTS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN COMPENSATED CIRRHOSIS — NOT_YET_RECRUITING
Hepatocellular Carcinoma in HIV-infected Patients — COMPLETED
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa — COMPLETED
Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection — WITHDRAWN · NA
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B — OTHER · PHASE4
Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient — COMPLETED · PHASE1
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients — OTHER · PHASE2
A PHASE 2B MULTI-CENTRE, RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE EFFICACY AND SAFETY OF SEQUENTIAL TREATMENT WITH GSK3228836 FOLLOWED BY PEGYLATED INTERFERON ALPHA 2A IN PARTIFICAPNTS WITH CHRONIC HEPATITIS B VIRUS (B-TOGETHER) — COMPLETED · PHASE2
Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment — COMPLETED · PHASE1
AN OPEN LABEL, SINGLE ARM STUDY TO MECHANISTICALLY INTERROGATE THE THERAPEUTIC EFFECT OF GSK3228836 IN PATIENTS WITH CHRONIC HEPATITIS B VIA INTRAHEPATIC IMMUNOPHENOTYPING — COMPLETED
A PHASE 2A, MULTICENTER, SINGLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE COHORT STUDY EVALUATING ABI-H2158-CONTAINING REGIMENS IN CHRONIC HEPATITIS B INFECTION — COMPLETED · PHASE2
A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection — COMPLETED · NA
PHASE IIB MULTI-CENTER, RANDOMISED, PARTIAL-BLIND, PARALLEL COHORT STUDY TO ASSESS THE EFFICACY AND SAFETY OF TREATMENT WITH GSK3228836 IN PARTICIPANTS WITH CHRONIC HEPATITIS B VIRUS (B-CLEAR) — COMPLETED · PHASE2
A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants — COMPLETED · PHASE1
A PHASE 1A/1B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF EDP-514 IN HEALTHY SUBJECTS (PART 1), AND ANTIVIRAL ACTIVITY IN NUCLEOS(T)IDE REVERSE TRANSCRIPTASE INHIBITOR (NUC)-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION (PART 2) — COMPLETED · PHASE1
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients — COMPLETED · PHASE1
Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus — OTHER
A PHASE 2B, MULTICENTER, DOUBLE-BLIND, ACTIVE-CONTROLLED, RANDOMIZED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DIFFERENT COMBINATION REGIMENS INCLUDING JNJ-73763989 AND/OR JNJ-5616379 FOR THE TREATMENT OF CHRONIC HEPTATIS B VIRUS INFECITON — COMPLETED · PHASE2

Refine this search